Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
1.79M
-
Shares change
-
+66.7K
-
Total reported value, excl. options
-
$7.48M
-
Value change
-
+$297K
-
Number of buys
-
6
-
Number of sells
-
-4
-
Price
-
$4.17
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2019
14 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q4 2019.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.79M shares
of 98M outstanding shares and own 1.83% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (595K shares), FMR LLC (491K shares), VIKING GLOBAL INVESTORS LP (229K shares), RENAISSANCE TECHNOLOGIES LLC (200K shares), VANGUARD GROUP INC (166K shares), Ensign Peak Advisors, Inc (37.9K shares), FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (22.6K shares), CITADEL ADVISORS LLC (13.8K shares), GEODE CAPITAL MANAGEMENT, LLC (13K shares), and Virtu Financial LLC (11.2K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.